Published in Volume
115, Issue 4 (April 1, 2005)
J Clin Invest. 2005;115(4):1100–1100.
doi:10.1172/JCI24282C1.
Copyright ©
2005, The American Society for
Clinical Investigation.
Corrigendum
Liver fibrosis
Ramón Bataller and David A. Brenner
Published April 1, 2005
Original citation: J. Clin. Invest.
115:209–218(2005). doi:10.1172/JCI24282
Citation for this corrigendum: J. Clin. Invest.
115:1100 (2005). doi:10.1172/JCI24282C1
PPARg agonists but not PPAR antagonists, as listed in Table 2, have shown inhibitory
effects on HSCs and antifibrotic effects in animal models with liver fibrosis and
patients with NASH.
The authors regret the error.
